Findings at diagnosis and during the course of TL significantly associated with a higher cumulative incidence of death (CID)
| Variable . | CID at 5 y, % . | PGray . | |
|---|---|---|---|
| Yes . | No . | ||
| At diagnosis | |||
| High WBC count (> 100 ×109/L) | 38 ± 11 | 12 ± 3 | .002 |
| Hydrops fetalis | 71 ± 17 | 12 ± 3 | < .001 |
| Ascites | 58 ± 14 | 11 ± 3 | < .001 |
| Effusions (pleural, pericardial, ascites, or hydrops) | 30 ± 8 | 11 ± 3 | .008 |
| Coagulopathy | 39 ± 10 | 11 ± 3 | < .001 |
| Bleeding diatheses | 67 ± 16 | 12 ± 3 | < .001 |
| Platelet levels > 100 × 109/L | 21 ± 5 | 6 ± 3 | .023 |
| Preterm delivery | 35 ± 8 | 8 ± 4 | .002 |
| Birth weight less than 3 kg | 33 ± 9 | 14 ± 4 | .021 |
| During course of disease | |||
| Cholestasis | 38 ± 12 | 12 ± 3 | .007 |
| Liver fibrosis | 100 ± 13 | 12 ± 3 | < .001 |
| Liver dysfunction | 31 ± 8 | 11 ± 3 | .003 |
| Renal failure | 100 | 11 ± 3 | < .001 |
| Variable . | CID at 5 y, % . | PGray . | |
|---|---|---|---|
| Yes . | No . | ||
| At diagnosis | |||
| High WBC count (> 100 ×109/L) | 38 ± 11 | 12 ± 3 | .002 |
| Hydrops fetalis | 71 ± 17 | 12 ± 3 | < .001 |
| Ascites | 58 ± 14 | 11 ± 3 | < .001 |
| Effusions (pleural, pericardial, ascites, or hydrops) | 30 ± 8 | 11 ± 3 | .008 |
| Coagulopathy | 39 ± 10 | 11 ± 3 | < .001 |
| Bleeding diatheses | 67 ± 16 | 12 ± 3 | < .001 |
| Platelet levels > 100 × 109/L | 21 ± 5 | 6 ± 3 | .023 |
| Preterm delivery | 35 ± 8 | 8 ± 4 | .002 |
| Birth weight less than 3 kg | 33 ± 9 | 14 ± 4 | .021 |
| During course of disease | |||
| Cholestasis | 38 ± 12 | 12 ± 3 | .007 |
| Liver fibrosis | 100 ± 13 | 12 ± 3 | < .001 |
| Liver dysfunction | 31 ± 8 | 11 ± 3 | .003 |
| Renal failure | 100 | 11 ± 3 | < .001 |